Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
A phase I study of intravenous bryostatin 1 in patients with advanced cancer
HTML
PDF
Details
Locations
Year:
1993
Type:
article
Study design:
Clinical Trial
Source:
British Journal of Cancer
DOI:
10.1038/bjc.1993.352
Authors:
J Prendiville,
D Crowther,
N Thatcher,
PJ Woll,
BW Fox,
A McGown,
N Testa,
P Stern,
R McDermott,
M Potter,
GR Pettit
show all 11
Institutions:
Cancer Research UK Manchester Institute,
The Christie Hospital,
The Christie NHS Foundation Trust,
Northern Care Alliance NHS Foundation Trust
Language:
English
Topic:
Marine Sponges and Natural Products
Subfield:
Biotechnology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
marine natural products,
Bugula neritina,
advanced solid tumors,
maximum tolerated dose,
dose-limiting toxicity,
myalgia,
hematologic toxicity,
neutrophil superoxide production,
NK cell cytotoxicity,
antitumour activity,
hematopoietic progenitor cells,
immunomodulation
show all 12
SDG:
Good health and well-being
Open Access status:
bronze
OpenAlex ID:
W2007069751
FWCI:
12.36
Cites:
36
Cited by:
155
Related to:
10